Synarel (Neolpharma, Inc.)


Welcome to the PulseAid listing for the Synarel drug offered from Neolpharma, Inc.. This Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Neolpharma, Inc.
NON-PROPRIETARY NAME: Nafarelin Acetate
SUBSTANCE NAME: NAFARELIN ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA]
ROUTE: NASAL
DOSAGE FORM: SPRAY, METERED
MARKETING CATEGORY NAME: APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT
START MARKETING DATE: 1990-02-13
END MARKETING DATE: 0000-00-00


Synarel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSynarel from Neolpharma, Inc.
LABELER NAME: Neolpharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 1990-02-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55466-723_5c8bde5a-58ef-085f-e053-2991aa0a56af
PRODUCT NDC: 55466-723
APPLICATION NUMBER: NDA019886

Other NAFARELIN ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
G.D. Searle LLC Division of Pfizer IncSynarel
Neolpharma, Inc.Synarel